These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 16425203

  • 1. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL, Harya NS, Monzon FA, Maier CE, O'Keefe DS.
    Prostate; 2006 May 15; 66(7):687-95. PubMed ID: 16425203
    [Abstract] [Full Text] [Related]

  • 2. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM, Ramachandran K, Vanwert J, Ferdinand L, Gopisetty G, Reis IM, Singal R.
    Mol Cancer; 2006 Jul 18; 5():28. PubMed ID: 16848908
    [Abstract] [Full Text] [Related]

  • 3. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 18; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 4. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 18; 14(5):1274-8. PubMed ID: 15894685
    [Abstract] [Full Text] [Related]

  • 5. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.
    J Natl Cancer Inst; 2006 Feb 15; 98(4):255-61. PubMed ID: 16478744
    [Abstract] [Full Text] [Related]

  • 6. Dual role of TMS1/ASC in death receptor signaling.
    Parsons MJ, Vertino PM.
    Oncogene; 2006 Nov 02; 25(52):6948-58. PubMed ID: 16715133
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
    Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF.
    Clin Cancer Res; 2003 Oct 15; 9(13):4730-4. PubMed ID: 14581343
    [Abstract] [Full Text] [Related]

  • 8. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, Palotie AV, Belldegrun AS.
    Prostate; 2003 Apr 01; 55(1):71-80. PubMed ID: 12640663
    [Abstract] [Full Text] [Related]

  • 9. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH, Lee S, Lee HJ, Hwang KS.
    J Pathol; 2004 Feb 01; 202(2):233-40. PubMed ID: 14743506
    [Abstract] [Full Text] [Related]

  • 10. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.
    Carvalho JR, Filipe L, Costa VL, Ribeiro FR, Martins AT, Teixeira MR, Jerónimo C, Henrique R.
    Apoptosis; 2010 Aug 01; 15(8):956-65. PubMed ID: 20464497
    [Abstract] [Full Text] [Related]

  • 11. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y, Tong D, Lou G, Zhang Y, Geng J.
    Pathobiology; 2008 Aug 01; 75(4):244-51. PubMed ID: 18580070
    [Abstract] [Full Text] [Related]

  • 12. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance.
    Liu XF, Zhu SG, Zhang H, Xu Z, Su HL, Li SJ, Zhou XT.
    Hepatobiliary Pancreat Dis Int; 2006 Aug 01; 5(3):449-53. PubMed ID: 16911948
    [Abstract] [Full Text] [Related]

  • 13. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.
    Breast Cancer Res; 2008 Aug 01; 10(5):R82. PubMed ID: 18826564
    [Abstract] [Full Text] [Related]

  • 14. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627
    [Abstract] [Full Text] [Related]

  • 15. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.
    Sathyanarayana UG, Padar A, Suzuki M, Maruyama R, Shigematsu H, Hsieh JT, Frenkel EP, Gazdar AF.
    Clin Cancer Res; 2003 Dec 15; 9(17):6395-400. PubMed ID: 14695140
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

  • 17. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 06; 7(6):531-6. PubMed ID: 9641498
    [Abstract] [Full Text] [Related]

  • 18. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
    Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, Li LC, Okino ST, Deguchi M, Kaneuchi M, Terashima M, Yoneda T, Shigeno K, Carroll PR, Igawa M, Dahiya R.
    Cancer Res; 2005 Mar 15; 65(6):2130-8. PubMed ID: 15781623
    [Abstract] [Full Text] [Related]

  • 19. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
    Lou W, Krill D, Dhir R, Becich MJ, Dong JT, Frierson HF, Isaacs WB, Isaacs JT, Gao AC.
    Cancer Res; 1999 May 15; 59(10):2329-31. PubMed ID: 10344738
    [Abstract] [Full Text] [Related]

  • 20. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP.
    Cancer Res; 2005 Feb 15; 65(4):1164-73. PubMed ID: 15734999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.